Results 111 to 120 of about 15,343 (151)

631 Potential pro-proliferative function of polo-like kinase 4 in human melanoma [PDF]

Journal of Investigative Dermatology, 2016
M. Shabbir, M. Nihal, C.K. Singh, B. Longley, N. Ahmad   +4 more
openaire   +1 more source

RETRACTION: Polo-Like Kinase 4 Correlates With Greater Tumor Size, Lymph Node Metastasis, and Confers Poor Survival in Non-Small Cell Lung Cancer. [PDF]

J Clin Lab Anal
europepmc   +1 more source

Polo-like kinase 4 maintains centriolar satellite integrity by phosphorylation of centrosomal protein 131 (CEP131). [PDF]

J Biol Chem, 2019
Denu RA, Sass MM, Johnson JM, Potts GK, Choudhary A, Coon JJ, Burkard ME.   +6 more
europepmc   +1 more source

Polo-like kinase 4 mediates epithelial-mesenchymal transition in neuroblastoma via PI3K/Akt signaling pathway. [PDF]

Cell Death Dis, 2018
Tian X, Zhou D, Chen L, Tian Y, Zhong B, Cao Y, Dong Q, Zhou M, Yan J, Wang Y, Qiu Y, Zhang L, Li Z, Wang H, Wang D, Ying G, Zhao Q.   +16 more
europepmc   +1 more source

Polo-like kinase 4 correlates with greater tumor size, lymph node metastasis and confers poor survival in non-small cell lung cancer.

J Clin Lab Anal, 2020
Zhou Q, Fan G, Dong Y.
europepmc   +1 more source

Asterless is a Polo-like kinase 4 substrate that both activates and inhibits kinase activity depending on its phosphorylation state. [PDF]

Mol Biol Cell, 2018
Boese CJ, Nye J, Buster DW, McLamarrah TA, Byrnes AE, Slep KC, Rusan NM, Rogers GC.   +7 more
europepmc   +1 more source

Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma. [PDF]

Oncotarget, 2017
Sredni ST, Bailey AW, Suri A, Hashizume R, He X, Louis N, Gokirmak T, Piper DR, Watterson DM, Tomita T.   +9 more
europepmc   +1 more source

Activity of the novel polo-like kinase 4 inhibitor CFI-400945 in pancreatic cancer patient-derived xenografts. [PDF]

Oncotarget, 2017
Lohse I, Mason J, Cao PM, Pintilie M, Bray M, Hedley DW.   +5 more
europepmc   +1 more source

Expression of Polo-Like Kinase 4(PLK4) in Breast Cancer and Its Response to Taxane-Based Neoadjuvant Chemotherapy. [PDF]

J Cancer, 2016
Li Z, Dai K, Wang C, Song Y, Gu F, Liu F, Fu L.   +6 more
europepmc   +1 more source

Monoclonal Antibodies Accessing the Cytosol of Living Cells and Binding to Polo-Like Kinase 1 Interdomain Linker Affect Mitotic Behavior. [PDF]

Chembiochem
Steyer C, Amé JC, Donzeau M, Shen K, Chiper M, Zuber G.   +5 more
europepmc   +1 more source